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ABSTRACT
Objectives To explore if consumer interest in digital 
health products (DHPs), changed following the COVID- 19 
pandemic and the lockdown measures that ensued.
Design Retrospective time- series analysis of web- based 
internet searches for DHPs in the UK, split over two 
periods, pre- COVID- 19 lockdown (January 2019–23 March 
2020) and post- COVID- 19 lockdown (24 March 2020–31 
December 2020).
Setting The UK.
Participants Members of the UK general population using 
health- app libraries provided by the Organisation for the 
Review of Care and Health Applications.
Primary and secondary outcome measures The 
primary outcome was volume of searches for DHPs. 
Secondary outcomes considered search volumes for 25 
different therapeutic areas. Outcomes were assessed for 
significance using a two- stage Poisson test.
Results There were 126 640 searches for DHPs over the 
study period. Searches for DHPs increased by 343% from 
2446 per month prior to COVID- 19 lockdown measures 
being introduced to 8996 per month in the period 
following the first COVID- 19 lockdown in the UK. In total, 
23/25 (92%) of condition areas experienced a significant 
increase in searches for DHPs, with the greatest increases 
occurring in the first 2 months following lockdown. 
Musculoskeletal conditions (2,036%), allergy (1,253%) 
and healthy living DHPs (1,051%) experienced the greatest 
increases in searches compared with pre- lockdown. 
Increased search volumes for DHPs were sustained in the 
9 months following the introduction of lockdown measures, 
with 21/25 (84%) of condition areas experiencing monthly 
search volumes at least 50% greater than pre- lockdown 
levels.
Conclusions The COVID- 19 pandemic has profoundly 
disrupted the routine delivery of healthcare, making face- 
to- face interaction difficult, and contributing to unmet 
clinical needs. This study has demonstrated significant 
increases in internet searches for DHPs by members of 
the UK population since COVID- 19, signifying an increased 
interest in this potential therapeutic medium. Future 
research should clarify whether this increased interest has 
resulted in increased acceptance and utilisation of these 
technologies also.
INTRODUCTION
The traditional model of healthcare delivery 
is based on providing medical services 
through systems of hospitals, primary care 
facilities and outpatient clinics.1 However, 
the COVID- 19 pandemic has profoundly 
disrupted the routine delivery of physical 
healthcare, resulting in the widespread 
Strengths and limitations of this study
 ► This study is a first of its kind in using real- world in-
ternet search data for digital health products (DHPs), 
providing novel insights into consumer interest in 
this novel therapeutic medium.
 ► Segmentation of data into 25 different condition ar-
eas has enabled exploration of the interest in digital 
health (at the condition level) in previously unex-
plored ways.
 ► The collection of data from members of the UK gen-
eral public, in significant numbers, allows generali-
sation beyond this study, suggesting that DHPs may 
be a valuable tool in the event of further COVID- 19 
lockdown measures.
 ► A limitation of the study is that searches for DHPs 
do not always result in downloads and subsequent 
usage, limiting interpretation in terms of what we 
believe the observed increase in internet searches 
for DHPs means in terms of improvements in tangi-
ble health outcomes.
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deferral of elective, preventive and outpatient appoint-
ments by health authorities.2–4 Estimates suggest that as 
many as 40% of appointments have been cancelled or 
postponed by patients, as part of efforts to avoid public 
spaces as much as possible.5 In the USA, ambulatory care 
visits fell by 60% in the early phase of the pandemic,6 
while in the UK alone, an estimated 1.5 million elective 
admissions and 2.6 million outpatient attendances were 
forgone as a result of COVID- 19.7 While the details of the 
longer- term impact of this significant change in access 
to services are unclear, short- term cracks are begin-
ning to emerge. Reduced access to services,8 restric-
tions on social contact and concerns regarding future 
employment insecurity have contributed to a significant 
increase in mental- health sequelae.9 Additionally, we are 
yet to observe the full impact that disruptions to cancer 
services may have. Cancer Research UK estimated that 
2400 fewer people started treatment for lung cancer in 
April–December 2020, compared with the same time in 
2019.10 Similarly, an estimated 344, 1563 and 342 avoid-
able deaths are expected to occur in the UK as a result of 
breast cancer, colorectal cancer and oesophageal cancer, 
respectively, with an estimated 63 229 years of life lost as 
a result.11
Given the increasing barriers to both accessing and 
using a variety of face- to- face health services, the poten-
tial for digital health to address at least some of the 
mounting unmet clinical needs has gained traction 
during the pandemic. Digital health products (DHPs) 
have been available for many years now, slowly increasing 
in popularity across a wide range of health- related appli-
cations in almost all sectors of healthcare.12 National 
bodies, including the National Institute for Health and 
Care Excellence (NICE), are now providing recom-
mendations and guidelines on both the utilisation and 
evaluation of DHPs.13 14 These technologies, which are 
widely accessible and fundamentally flexible, continue 
to provide an additional means to achieve a continuity 
of care among those with unmet medical needs.15 With 
many clinicians now realising the full potential of these 
digital tools, and becoming more accepting of DHPs as 
a potential therapeutic option during the COVID- 19 
pandemic, including not just notifiable medical devices, 
but also simpler diet and fitness applications, it is uncer-
tain how consumer attitudes, interest and demand for 
DHPs have changed during this period. Using data from 
the world’s largest digital health evaluation formulary, 
provided by the Organisation for the Review of Care and 
Health Applications (ORCHA),16 with over 10 000 DHPs 
reviewed to date, the aim of this study is to determine 
how internet searches for DHPs for various health condi-
tions has changed since COVID- 19 lockdown measures 
were introduced in March 2020 and throughout the 
pandemic. Furthermore, this study will also explore 
whether changes in search volumes for DHPs differed by 
therapeutic area.
MATERIALS AND METHODS
The methodology for this study is a retrospective time- 
series analysis of real- world internet searches for DHPs 
within ORCHA’s digital health library, split over two time 
periods, before and after the initiation of COVID- 19 lock-
down procedures in the UK, which commenced on 23 
March 2020. For the purpose of this analysis, DHPs were 
defined as health apps, including all health apps with 
the potential to improve health outcomes, not limited 
to medical devices, but also including diet and fitness 
health apps. Our aim was to determine if searches for 
DHPs changed following the first phase of lockdown, and 
throughout the pandemic. Additionally, the study aims 
to explore whether changes in search volumes for DHPs 
differed by therapeutic area.
ORCHA are the world’s largest independent reviewer 
of DHPs, providing a repository of DHPs, evaluated using 
a ~350 point objective ‘yes’ or ‘no’ scale. These questions 
take into account a variety of factors, including user expe-
rience and usability, clinical assurance and evidence of 
effectiveness, clinical safety, and data privacy.16 To date 
more than 10 000 DHPs have been reviewed and included 
on ORCHA’s ‘app- finder’ website. During the period of 
analysis, ORCHA health- app libraries were procured by 
councils, NHS trusts, clinical commissioning groups and 
integrated care systems in approximately 70% of NHS 
regions, providing the ORCHA health- app library free to 
use, to healthcare providers and members of the public 
alike. Additionally, during this time period, anyone in 
the UK could access the ORCHA health- app library free 
of charge by simply typing ORCHA into their chosen 
search engine. For the purpose of this study, user’s digital 
health search term data, used across all ORCHA digital 
health libraries from 1 January 2019 to 31 December 
2020, were collected using Google Analytics. We removed 
2486 searches which were exclusively alphanumeric, 
clear typos, or which consisted of just two letters or less. 
Following this process, there were 126 640 web searches 
for DHPs within the study period, equal to approximately 
5276 searches per month. From this group of 126 640 
searches, we identified every unique search term, deter-
mining the frequency of use for each over the study 
period. In order to explore the different types of DHPs 
searched for, search terms were subsequently attributed 
to one of 25 condition areas. These condition areas 
were identified following multidisciplinary input from 
three healthcare professionals (a midwife, a pharmacy 
specialist lead and an ophthalmologist) and a health 
economist, with the aim of covering a broad representa-
tion of functions and conditions throughout the human 
body. An iterative process was used where each contrib-
utor added to (or recommended removing conditions) 
from the contribution of the last. Once all contributors 
had the opportunity to recommend therapeutic areas for 
inclusion, a final discussion between all four contribu-
tors took place, at which point the condition areas were 
finalised. We developed an expansive list of search terms 
attributable to each of the 25 condition areas, using both 
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MESH headings and condition- specific terms (such as 
insulin in the case of diabetes, or inhalers for asthma) 
following methodological guidance for the purpose of 
literature reviewing. Each of the four contributors then 
provided independent iterative curation of the search 
terms, creating a quality control chain. In the event that 
search terms were missed, they were added and synonyms 
provided. The search strings used to tag and classify the 
unique search terms into each of the 25 condition areas 
are provided in online supplemental file 1.
Remaining terms which had not been initially attributed 
to one of the 25 condition areas were then attributed 
using an iterative two- phase tagging approach. First, we 
used data from the digital health libraries to identify the 
names of DHPs associated with each of the 25 condition 
areas. We used a list of the names of the most commonly 
searched DHPs for each condition, which were then also 
added to the relevant search strings. This was supple-
mented by asking a team of several digital health assessors 
to provide the names of any DHPs they could recall for 
each of the 25 condition areas. While most DHPs tended 
to include the name of the condition within the name of 
the DHP, and, therefore, would have been automatically 
attributed to a condition, this method was particularly 
useful for DHPs with names that did not obviously link 
to a condition area, such as Wysa in the case of mental 
health, or Xploro for oncology. Following this process, 
search terms which had not already been attributed to a 
condition area (untagged) were ordered from the most 
to least searched (frequency of searches) and reviewed 
by two independent researchers. Researchers manually 
descended the list of terms, and in the event, terms were 
related to one of the 25 condition areas; they were added 
to the pre- existing search strings. Due to the gamma 
distribution of search term frequency (non- negative with 
a significant positive skew), reviewers stopped classifying 
search terms for any term with less than 10 searches over 
the 2- year period of investigation. This figure was the cut- 
off for classification as it was at this point that clear typos 
and alphanumeric searches which could not clearly be 
linked to either condition areas with any certainty were 
most common.
Statistical analysis
Given the differential time periods for data collection 
and analysis (~15 months before lockdown measures 
were introduced in the UK on 23 March 2020, and ~9 
months after), search frequencies were standardised by 
determining the mean number of searches per calendar 
month. The overall change in search frequency (and for 
DHPs associated with each of the 25 condition areas), 
between the two time periods under consideration, was 
determined by comparing the mean frequency of searches 
(per month) before and after 23 March 2020 (COVID- 19 
lockdown). A two- sample Poisson test was used to identify 
if any changes in the volume of web searches for DHPs, 
both overall, and by condition area, were statistically 
significant at the conventional 95% level. Data cleaning 
was performed using Microsoft Office Excel 2013 (Micro-
soft, Redmond, Washington, DC, USA), with all statistical 
analyses conducted using Stata V.14.
Patient and public involvement
For this retrospective study of real- world DHP search 




In the period prior to COVID- lockdown measures being 
introduced (1 January 2019–23 March 2020), 36 685 
searches for DHPs were undertaken using ORCHA digital 
health libraries, equivalent to 2446 per month. As detailed 
in table 1, DHPs dedicated to mental health, diabetes 
and healthy living were the most frequently searched for 
during this period. In the period following the introduc-
tion of lockdown measures (24 March 2020 onwards), a 
total of 89 955 searches for DHPs took place, equivalent 
to 8996 per month, a 343.4% increase on the previous 
period (p<0.0001).
Searches for DHPs by condition area
There was substantial variation in changes in DHP 
search frequency by condition area (pre- COVID- 19 vs 
post COVID- 19 lockdown), as demonstrated in table 1. 
COVID- 19, musculoskeletal (MSK) and physiotherapy, 
allergy and fitness/diet and weight loss DHPs experi-
enced ~4,622%, ~2,036%, ~1,253% and ~1,051% increases 
in monthly searches for DHPs following COVID- 19 lock-
down measures, the largest increases observed. Every 
condition area, other than carer support and guidance/
info, experienced a statistically significant increase in 
searches for DHPs in the period following COVID- 19 
lockdown measures.
Searches for DHPs by condition area, over time
While the increased frequency of searches for DHPs 
occurred immediately following the introduction of lock-
down proceedings, as demonstrated within figure 1, the 
interest in DHPs in different condition areas was sustained 
over the 9- month period following COVID- 19 lockdown 
measures. In total, 23/25 (92%) of the condition areas 
analysed experienced monthly search volumes at least 
25% greater than pre- lockdown levels, 21/25 (84%) had 
monthly search volumes at least 50% greater than pre- 
lockdown levels and 14/25 (56%) experienced search 




The study provides a first- of- its- kind exploration of the 
impact of COVID- 19, and the ensuing difficulties in 
accessing face- to- face care, on consumer interest for 
DHPs under real- world conditions. Using 2 years of 
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retrospective data (January 2019–December 2020) from 
the world’s largest formulary of DHPs, available to health-
care providers and members of the public in the UK, 
we observed a significant increase in searches for DHPs. 
Searches for DHPs increased by 343% from an average 
2446 per month prior to COVID- 19 lockdown measures 
being introduced to an average 8996 per month in the 
9- month period following the first COVID- 19 lockdown. 
Despite observing a statistically significant increase in 
searches for DHPs for all but two of the 25 condition areas 
listed, increases in searches varied substantially by condi-
tion area, with MSK and physiotherapy (2,036%), allergy 
(1,253%) and fitness, diet and weight loss (1,051%) 
DHPs experiencing the greatest increases in searches. 
While searches for DHPs should not be considered a 
perfect proxy for DHP acceptance, downloads and usage, 
the data presented here suggest that openness to consid-
ering DHPs, and at least researching these tools for the 
purpose of independent condition and health manage-
ment, increased following COVID- 19 lockdowns.
The strengths of this analysis include the fact that the 
dataset used includes over 125 000 searches for DHPs by 
members of the public from the UK, over a 2- year period. 
As such, when increases in searches for DHPs were 
observed post- COVID- 19 lockdown, the likelihood of this 
being down to random chance is minimised through the 
extensive periods of analysis and the high frequency of 
search data, both pre- lockdown and post- lockdown, under 
consideration. Additionally, segmentation of search data 
into different condition areas allowed exploration of 
internet search volumes for digital health technologies in 
previously unexplored ways. There are, however, several 
Table 1 Comparison of search frequency pre- COVID- 19 and post- Covid- 19 lockdown measures, by condition area
Category
Searches per month pre- 
lockdown* (mean)
Searches per month post- 
lockdown† (mean) Increase (%) Significance‡
COVID 4 197 4622.4 p<0.01
Musculoskeletal and 
physiotherapy
34 683 2035.5 p<0.01
Allergy 4 45 1253.1 p<0.01
Fitness, diet and weight loss 320 1663 1050.8 p<0.01
Gastroenterology 12 92 767.6 p<0.01
Ears and hearing 22 152 700.0 p<0.01
Kidney 4 27 632.3 p<0.01
Children’s health 34 211 613.6 p<0.01
Neurological and 
neurodevelopmental
119 698 588.3 p<0.01
Cancer 22 131 581.1 p<0.01
Women’s health 27 158 576.5 p<0.01
Respiratory 78 398 510.4 p<0.01
Men’s health 4 18 487.9 p<0.01
Heart 31 131 422.9 p<0.01
Dental 3 13 399.3 p<0.01
Pain and chronic fatigue 49 191 389.6 p<0.01
Nose and throat 1 5 363.6 p<0.01
Mental health 723 2536 350.7 p<0.01
Pregnancy 48 161 338.2 p<0.01
Eyes and vision 11 29 255.8 p<0.01
Diabetes 244 589 241.8 p<0.01
Addiction 136 274 201.4 p<0.01
Sleep 259 474 183.0 p<0.01
Guidance and info 21 16 74.3 p=0.64
Carer 45 28 63.2 p=0.14
Combined 2256 8920 395 N/A
*Starts from January 2019 to 23 March 2020 (~15 months).
†Starts from 24 March 2020 to the end of December 2020 (~9 months).
‡Significance determined using two- staged Poisson test.
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limitations of this analysis, which must also be considered 
when interpreting the findings. First, this analysis focused 
exclusively on searches for DHPs. While this in itself is not 
a limitation, and was the subject of the research question, 
searches do not always result in downloads and subse-
quent usage, nor do they signify acceptance of such tech-
nologies, or a changing of beliefs towards digital health 
Therefore, while we can say with relative certainty that 
interest in DHPs as proxied by internet search volumes, 
and consideration of their potential usage as therapeutic 
options increased as a result of COVID- 19 lockdown 
measures, we cannot definitively confirm whether this 
increased interest generated tangible improvements in 
health as a result. Second, while every attempt was made 
to ensure that the conditions under consideration were 
varied and representative, using an iterative process of 
healthcare provider and researcher review, it is possible 
and also likely that both important and prevalent condi-
tions may not have been addressed by the analysis. 
This may affect the findings by underestimating (if web 
searches for the DHPs increased significantly) or over-
estimating (if web searches hardly changed) the impact 
that COVID- 19 had on web searches for DHPs. Similarly, 
although the process used to identify terms to classify 
DHPs was thorough and multidisciplinary, it is possible 
that DHPs could have been misclassified or missed alto-
gether. While it is unlikely that key terms were omitted, 
such as diabetes, cancer, mental health or smoking, it is 
possible that less obvious names of DHPs were missed, 
where the name of the DHP has no obvious medical link 
to the condition under consideration. This may have led 
to an underestimation of searches for condition- specific 
DHPs in the periods both pre- COVID- 19 and post- 
COVID- 19 lockdown. Finally, as ORCHA libraries are not 
the only place on the internet to search for health apps, 
we, therefore, cannot be sure that the findings observed 
here would be reflected in the wider population, nor can 
we be certain that the increased interest in searching for 
DHPs. Additionally, based on the existing study structure, 
there is no guarantee that the findings observed here will 
continue to be observed once the COVID- 19 pandemic 
has concluded, something which future research will 
need to address.
Interpretation in light of other evidence
We found that searches for DHPs increased by 343%, a 
statistically significant increase from 2446 per month 
prior to COVID- 19 lockdown measures to 8996 per month 
in the 9 months following the first COVID- 19 lockdown. 
Although this rise may plausibly be attributed to a shift 
Figure 1 How interest in digital health changed throughout the COVID- 19 pandemic?
 on O









pen: first published as 10.1136/bm





6 Leigh S, et al. BMJ Open 2021;11:e053891. doi:10.1136/bmjopen-2021-053891
Open access 
in treatment seeking behaviour for those experiencing 
denied or delayed access to routine face- to- face appoint-
ments with healthcare professionals,17–19 there could be 
alternative justifications for this observed increase in 
searches for DHPs. These include, but are not limited 
to, the widespread increase in acceptance of DHPs over 
time,20–22 and promotion of this relatively new therapeutic 
medium by health authorities. Previous studies, including 
two conducted by the authors of this study,23 24 have 
shown that recommendations from health authorities to 
use DHPs, including the NHS and NICE, can significantly 
enhance acceptance and utilisation. Recently, the UK has 
experienced a substantial increase in regulative clarity, 
and with this, recommendations considering potential 
uses of digital health have increased significantly; these 
include the recent release of the NHSX digital technology 
assessment criteria,25 and revisions to NICE evidence stan-
dards framework.14 As such, at least some of the increases 
seen here may have been attributable to latent shifts in 
attitudes towards digital health, although accelerating 
them as a result of COVID- 19.
Another key finding of this study concerned the 
impact that lockdown measures may have had, and across 
different condition areas, as the pandemic progressed. 
Initially, in the UK, leisure facilities, organised sports and 
the requirement to stay home, where possible, with the 
exception of one period of exercise a day, led to individ-
uals going out and taking part in physical activity, whether 
direct, including organised sports, or indirect, including 
walking to work, far less than previous. This indirectly may 
have made physical exercise more ‘attractive’ as an activity, 
as one of the only permissible reasons to leave home once 
a day. Therefore, it is to be expected that the need for 
fitness DHPs increased, as observed within this study. In 
the first 3 months following the first period of lockdown, 
internet searches for fitness- related DHPs increased by 
2000%. As the pandemic progressed, and people either 
worked from home more or were furloughed, which for 
many was a significant adjustment, the UK also observed 
a significant surge in alcohol consumption,4 with a corre-
sponding increase in internet searches for DHPs centred 
around addiction, as observed in this study.
What does this mean for clinical practice?
While it is unlikely that a face- to- face health service will 
ever be completely replaced by a virtual experience of 
any kind, there are clear signs that the healthcare system 
as we know it is on the verge of change. As evidenced 
by the findings of this study, it is clear that people are 
increasingly willing to consider digital health when 
contemplating seeking treatment for a variety of health 
conditions. DHPs offer the ability to gather more accurate 
timely information for healthcare appointments, allow 
advice to be reinforced and provide new convenient ways 
to connect with healthcare advice or professionals. Given 
the potential for a third wave of COVID- 19 restrictions 
in light of new variants, and increased transmissibility, it 
is, therefore, critical that consumers are directed to safe, 
trusted and evidence- based solutions, if the demand for 
such technologies should arise. This is critical such that 
any benefits which may be realised either in the absence 
of, or in addition to face- to- face services, are not overshad-
owed or negated by the potential dangers of using poten-
tially unsafe and unproven technologies. A large part of 
this process is informing, and enabling healthcare profes-
sionals to also recognise this opportunity, to become 
more actively involved in the provision of high- quality, 
trusted and safe DHPs for a variety of conditions. This 
is not limited solely to high functioning medical devices, 
but also to DHPs with the aim of improving lifestyle deci-
sions and promoting healthy living, with interest in DHPs 
from both ends of the spectrum increasingly significantly, 
as observed in this analysis.
Future research
Future research, which empirically explores attitudes 
towards digital health and the barriers and facilitators 
to use among members of the public, is likely to be of 
a significant value for the NHS in realising its long- term 
goals. This study has provided a basis for a hypothesis 
that the interest in digital health increased immediately 
following the introduction of COVID- 19 restrictions. 
These restrictions undoubtedly impacted access to incum-
bent services and, therefore, the argument may be made 
that DHPs were sought as an interim or ‘placeholder’ 
measure in order to fulfil unmet clinical needs. While 
this is a plausible hypothesis, it does require confirming, 
while the future role of DHPs beyond the pandemic, as 
things slowly begin to normalise, also requires explora-
tion. Attention should be paid to the specifics of DHPs 
and how willingness to use such technologies differs by 
functionality. It is plausible that members of the public 
were happy to use DHPs, which had limited functionality 
in the absence of being able to visit a qualified health-
care professional, but would have concerns about using 
DHPs classed as medical devices. This ‘classification’ of 
DHPs, and the different ‘types’ of DHP consumers are 
willing to use, is a largely unexplored area of research. 
Unfortunately, this could not be discerned in this anal-
ysis and should be addressed, in addition to the other 
points raised above, before we can determine whether the 
observed increase in searches for DHPs was a one- time 
occurrence, or indeed, the start of a new era of digital 
medicine.
CONCLUSION
The COVID- 19 pandemic has profoundly disrupted the 
routine delivery of healthcare, contributing to unmet clin-
ical needs and significant increases in related sequelae. 
Digital health has been posed as one solution to address 
unmet needs resulting from COVID- 19.
This study, which explored real- world interest in 
DHPs over a 2- year period, has demonstrated significant 
increases in internet searches for DHPs by members 
of the UK population since COVID- 19, signifying an 
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increased interest in this potential therapeutic medium. 
Searches for DHPs increased by 343%, with technologies 
dedicated to mental health and fitness among those expe-
riencing the greatest increases. Future research should 
clarify whether this increased interest has also resulted 
in increased acceptance and utilisation of these technol-
ogies also.
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